News
Two PQT Medicines trainings for regulators in 2022
Two PQT Medicines (virtual) trainings for regulators will take palce during June 2022.
Zhejiang Apeloa’s levofloxacin tablets prequalified
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Suspension of supply of COVID-19 vaccine (COVAXIN®)
The World Health Organization (WHO) is today confirming the suspension of supply of Covaxin produced by Bharat, through UN procurement agencies and recommending to countries that received the vacci
COVID-19 PANDEMIC AND EMERGENCY USE LISTING
Emergency Use Listing (EUL) for candidate in vitro diagnostics (IVDs) to detect SARS-CoV-2 remains ongoing.
Remdesivir added to COVID-19 Invitation for Expression of Interest (EOI)
Remdesivir invited for COVID-19:
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
Addition under section:
First entecavir products prequalified
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
First levonorgestrel intrauterine delivery system (IUS) prequalified
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
PRESENTATIONS AVAILABLE - Joint UNICEF‒UNFPA‒WHO Meeting for Manufacturers and Suppliers
Presentations of the Joint UNICEF-UNFPA-WHO Meeting with Manufacturers and Suppliers which took place from 08 to 10 March 2022 are now available on the following page:
MSN Labs’ darunavir tablets prequalified
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
First tocilizumab products for Covid-19 prequalified
WHO Prequalification Unit (PQT) added the below new products to its prequalified list: